This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Apr 30, 2026
•
1 min read
The FDA has classified a Class I recall for certain Omnipod 5 lots after a tubing defect was linked to 476 serious injuries.
Apr 28, 2026
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
I spoke with Gary Scheiner, CDCES, about why lows happen, how to treat them, and how to use your pump and CGM to reduce their frequency, duration, and severity.
Apr 24, 2026
The world's first one-year continuous glucose monitor is now available in Sweden, with Germany, Spain, and Italy to follow in the coming weeks.
The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.